The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment. Review uri icon

Overview

abstract

  • PURPOSE OF REVIEW: Modern therapeutics have led to improved survival for many types of cancer but have also been associated with adverse effects including potentially life-threatening cardiotoxicities. We sought to review the uses of multimodality cardiac imaging for risk stratification, prevention, and identification of cardiotoxicities in patients undergoing cancer treatment. RECENT FINDINGS: Advancements in both echocardiography and emerging modalities, like cardiac magnetic resonance imaging and cardiac computed tomography, continue to improve the pre- and during therapy cardiac evaluation of cancer patients. Echocardiography and cardiac magnetic resonance imaging, with the incorporation of global longitudinal strain, can identify overt and subclinical cancer therapy-related cardiac dysfunction and myocarditis, and stress echocardiography and cardiac computed tomography can noninvasively screen and monitor for coronary artery disease. Multimodality cardiac imaging is an evolving and critical tool for the pre-therapy screening and risk stratification, as well as during therapy surveillance of cancer treatment-related cardiotoxicity.

publication date

  • December 17, 2022

Research

keywords

  • Antineoplastic Agents
  • Neoplasms

Identity

Scopus Document Identifier

  • 85144186537

Digital Object Identifier (DOI)

  • 10.1161/CIR.0000000000001029

PubMed ID

  • 36527535

Additional Document Info

volume

  • 25

issue

  • 1